PharmaDD Top News: Business, Technology, Strategic Briefings - Tracking leading techniques and approaches in therapeutic drug discovery and development

 

Sponsored Links:
Prescription Drug Addiction

 

 

Press Releases 
FOR IMMEDIATE RELEASE

Cambridge Healthtech Institute and Pharma DD Magazine
Announce New “Best of Show” Awards

Awarded at Molecular Medicine Tri-Conference to 
recognize innovations in research, discovery and development

NEEDHAM, MA –November 28, 2006 – Cambridge Healthtech Institute, the leader in conference programming targeting science, biotechnology and pharmaceutical professionals, and the publisher of Pharma DD, today announced a new “Best of Show” Awards to be presented at the 14th International Molecular Medicine Tri-Conference. Judged by a team of leading industry experts and Pharma DD editors, the awards program spotlights new products that demonstrate exceptional technology and innovation in research, discovery, and development. 
Exhibitors at the upcoming Molecular Medicine Tri-Conference, taking place February 27 – March 2, 2006 at the Moscone North Convention Center in San Francisco, CA, are invited to submit their products and services for the “Best of Show” Awards. An online submission form and additional information are available at www.pharmadd.com/bestofshow. Submissions are due by February 2, 2007.

“The world’s leading drug discovery and development technologies and approaches will be showcased at the Molecular Medicine Tri-Conference,” says Pharma DD Editor-in-Chief Malorye A. Branca. “These tools are critical in accelerating and improving the drug discovery and development process, which is the major focus of Pharma DD,”

“Best of Show” Awards will be given in the following five technology categories: Genomics, Proteomics, Informatics, Chemistry, and Preclinical. A panel of judges including leading business and technology experts and Pharma DD Editor-in-Chief, Malorye A. Branca, will select up to three finalists in each category prior to the event, and will announce one winner in each category after meeting with the finalists and reviewing their products at the show. Finalists and winners alike will benefit from pre-at- and post- event program marketing efforts recognizing their achievements. Winners will be announced and presented with their awards on the show floor, March 1. 

As a Leading Media Sponsor of Molecular Medicine Tri-Conference, Pharma DD’s editors will be providing editorial coverage of the conference as well as the “Best of Show” Awards. Additional information about the Pharma DD “Best of Show” Awards can be obtained by sending an email to bestofshow@pharmadd.com, or by calling Gina Bajenaru at 781-972-1352. Find out information about the Molecular Medicine Tri-Conference by visiting www.Tri-Conference.com 

About Cambridge Healthtech Institute
CHI’s renowned conferences are the underpinning for all our other information resources. Each year, CHI organizes over 80 conferences held throughout the US. including The Molecular Medicine Tri-Conference, Beyond Genome, PepTalk, World Pharmaceutical Congress and the new acquired Bio-IT World Conference + Expo. The company strives to develop quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business. Leading researchers and business experts from top pharmaceutical, biotech and academic organizations present their most current findings in a forum that features panel discussions and audience participation. Over the past 14 years, CHI has produced more than 400 conferences, attracting more than 50,000 attendees from around the world. 

In addition to CHI’s vast conference portfolio, their media properties include PharmaWeek, available on the web only, Pharma DD, and Bio-IT World.

About Pharma DD
Pharma DD, published 6x per year, provides senior researchers and scientific management with unique insight into the industry-leading techniques and approaches driving new therapeutic discovery and development. As well as focusing on business issues, regulatory considerations, clinical trials, and post-approval safety issues. The publication and accompanying web site www.pharmaDD.com, deliver features, news, commentaries, and case studies to professionals in pharma, biotech, and research laboratories. Pharma DD is published by Cambridge Healthtech Institute, based in Needham, MA. 


For more information, contact: 
Gina Bajenaru
Cambridge Healthtech Institute
Ph. (781) 972-1352
gbajenaru@healthtech.com

Press Contact :
Lisa Scimemi
Cambridge Healthtech Institute
Ph. (617) 630-1319

lscimemi@healthtech.com